{
    "medicine_id": "78d960091d6c4cbdf6b3736b33123adfd16eafe2",
    "platform_id": "DB00019",
    "metadata": {
        "name": "Cegfila 6 mg 0 6mL Injection",
        "composition": "6 mg 0 6mL Pegfilgrastim",
        "clinical_particulars": {
            "therapeutic_indications": "Pegfilgrastim is indicated to decrease the incidence of infection as manifested by febrile neutropenia in patients with non myeloid malignancies receiving myelosuppressive anti cancer drugs associated with a clinically significant incidence of febrile neutropenia L9746 It is also indicated to increase survival in patients acutely exposed to myelosuppressive doses of radiation Hematopoietic Subsyndrome of Acute Radiation Syndrome L9746",
            "contraindications": {
                "disease": "The maximum safe dose of pegfilgrastim has not been established however the highest dose used in clinical trials was 300 mcg kg L9782 Overdosage of pegfilgrastim may result in leukocytosis and bone pain Events of edema dyspnea and pleural effusion have been reported in a single patient who self administered pegfilgrastim on 8 consecutive days in error In the event of overdose the patient should be monitored for signs and symptoms of toxicity and responded with appropriate general supportive care L9746 L9782",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Pegfilgrastim is a recombinant human granulocyte colony stimulating factor G CSF that promotes the production proliferation and maturation of neutrophils which are white blood cells involved in both innate and adaptive immune responses A187631 L9782 The safety and efficacy of pegfilgrastim in reducing the risk of febrile neutropenia and infections have been demonstrated in various tumor types and settings A187631 During chemotherapy induced neutropenia the clearance of pegfilgrastim is significantly reduced and the concentration of pegfilgrastim is sustained until the onset of neutrophil recovery A29 Serum concentrations of pegfilgrastim decline as the neutrophil count increases as neutrophil and neutrophil precursors are involved in cell mediated clearance of the drug A187601 Due the addition of polyethylene glycol group to its structure Pegfilgrastim is a long acting form of filgrastim with an extended serum half life and reduced renal clearance A187607 Although it is more slowly absorbed than filgrastim self regulation of pegfilgrastim is more efficient and the drug effects are maintained during one chemotherapy cycle 2 3 weeks A29",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00531",
                        "description": "The risk or severity of pulmonary toxicity can be increased when Pegfilgrastim is combined with Cyclophosphamide"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "The risk or severity of neutropenia can be increased when Pegfilgrastim is combined with Topotecan"
                    },
                    {
                        "drugbank-id": "DB00008",
                        "description": "The therapeutic efficacy of Pegfilgrastim can be decreased when used in combination with Peginterferon alfa 2a"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The therapeutic efficacy of Peginterferon alfa 2b can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB00059",
                        "description": "The therapeutic efficacy of Pegaspargase can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB00061",
                        "description": "The therapeutic efficacy of Pegademase can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB00082",
                        "description": "The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB01839",
                        "description": "The therapeutic efficacy of Propylene glycol can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB03394",
                        "description": "The therapeutic efficacy of Heptaethylene glycol can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB04895",
                        "description": "The therapeutic efficacy of Pegaptanib can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB05202",
                        "description": "The therapeutic efficacy of Egaptivon pegol can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB05321",
                        "description": "The therapeutic efficacy of PEG uricase can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB05860",
                        "description": "The therapeutic efficacy of Peginterferon alfacon 1 can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB06022",
                        "description": "The therapeutic efficacy of GlycoPEG GCSF can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB06293",
                        "description": "The therapeutic efficacy of Pegnivacogin can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB06325",
                        "description": "The therapeutic efficacy of Pegpleranib can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB06611",
                        "description": "The therapeutic efficacy of Pegsunercept can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB06811",
                        "description": "The therapeutic efficacy of Polidocanol can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The therapeutic efficacy of Peginesatide can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The therapeutic efficacy of Certolizumab pegol can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB09107",
                        "description": "The therapeutic efficacy of Methoxy polyethylene glycol epoetin beta can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB09122",
                        "description": "The therapeutic efficacy of Peginterferon beta 1a can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB09208",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB09287",
                        "description": "The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB09329",
                        "description": "The therapeutic efficacy of Antihemophilic Factor Recombinant PEGylated can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB11077",
                        "description": "The therapeutic efficacy of Polyethylene glycol 400 can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB11567",
                        "description": "The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB11661",
                        "description": "The therapeutic efficacy of Eptacog alfa pegol activated can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB11707",
                        "description": "The therapeutic efficacy of Olaptesed Pegol can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB12258",
                        "description": "The therapeutic efficacy of Abicipar Pegol can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB12578",
                        "description": "The therapeutic efficacy of Lexaptepid Pegol can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB12814",
                        "description": "The therapeutic efficacy of Cepeginterferon alfa 2B can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB12839",
                        "description": "The therapeutic efficacy of Pegvaliase can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB12842",
                        "description": "The therapeutic efficacy of Pegamotecan can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB13200",
                        "description": "The therapeutic efficacy of Lipegfilgrastim can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB13933",
                        "description": "The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB14700",
                        "description": "The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB14712",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB00309",
                        "description": "The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vindesine"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vinorelbine"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vincristine"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB05168",
                        "description": "The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vintafolide"
                    },
                    {
                        "drugbank-id": "DB11641",
                        "description": "The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vinflunine"
                    },
                    {
                        "drugbank-id": "DB13374",
                        "description": "The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vincamine"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}